Kidney cancer management 3.0: can artificial intelligence make us better?

Journal: Current opinion in urology
Published Date:

Abstract

PURPOSE OF REVIEW: Artificial intelligence holds tremendous potential for disrupting clinical medicine. Here we review the current role of artificial intelligence in the kidney cancer space.

Authors

  • Matthew Lee
    Department of Urology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
  • Shuanzeng Wei
    Department of Pathology.
  • Jordan Anaokar
    Department of Diagnostic Imaging, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Robert Uzzo
    Division of Urologic Oncology.
  • Alexander Kutikov
    Division of Urologic Oncology.